Bioventus annual current ratio
2020
2021
2022
2023
2024
2025
Bioventus Current Ratio Growth & History (BVS)
Bioventus's current ratio was 1.70 for fiscal 2025.
View full Bioventus company overviewBioventus annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.70 | 0.39 | +29.87% |
| 2024 | 2024-12-31 | 1.31 | −0.22 | −14.22% |
| 2023 | 2023-12-31 | 1.53 | 0.63 | +70.32% |
| 2022 | 2022-12-31 | 0.90 | −0.56 | −38.37% |
| 2021 | 2021-12-31 | 1.45 | −0.27 | −15.80% |
| 2020 | 2020-12-31 | 1.73 | — | — |
Bioventus quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-27 | 1.69 | 0.21 | +13.97% |
| Q1 2026 | 2026-03-28 | 1.69 | 0.26 | +18.21% |
| Q4 2025 | 2025-12-31 | 1.70 | 0.39 | +29.87% |
| Q3 2025 | 2025-09-27 | 1.74 | 0.32 | +22.96% |
| Q2 2025 | 2025-06-28 | 1.48 | 0.15 | +11.06% |
| Q1 2025 | 2025-03-29 | 1.43 | −0.11 | −6.99% |
| Q4 2024 | 2024-12-31 | 1.31 | −0.22 | −14.22% |
| Q3 2024 | 2024-09-28 | 1.41 | −0.14 | −8.94% |
| Q2 2024 | 2024-06-29 | 1.33 | −0.12 | −8.30% |
| Q1 2024 | 2024-03-30 | 1.53 | −0.04 | −2.55% |
| Q4 2023 | 2023-12-31 | 1.53 | 0.63 | +70.32% |
| Q3 2023 | 2023-09-30 | 1.55 | 0.61 | +64.98% |
| Q2 2023 | 2023-07-01 | 1.46 | 0.06 | +4.42% |
| Q1 2023 | 2023-04-01 | 1.57 | 0.14 | +10.04% |
| Q4 2022 | 2022-12-31 | 0.90 | −0.56 | −38.37% |
| Q3 2022 | 2022-10-01 | 0.94 | −0.59 | −38.61% |
| Q2 2022 | 2022-07-02 | 1.39 | −0.44 | −24.00% |
| Q1 2022 | 2022-04-02 | 1.43 | −0.39 | −21.24% |
| Q4 2021 | 2021-12-31 | 1.45 | −0.27 | −15.80% |
| Q3 2021 | 2021-10-02 | 1.53 | — | — |
| Q2 2021 | 2021-07-03 | 1.83 | — | — |
| Q1 2021 | 2021-04-03 | 1.82 | — | — |
| Q4 2020 | 2020-12-31 | 1.73 | — | — |
Bioventus current ratio trends
Over the last five fiscal years, Bioventus's current ratio decreased from 1.73 to 1.70, a change of −0.03. The latest reported quarter, Q2 2026, shows 1.69.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus source filings ↗